Mayne Pharma Group Limited

MYX

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. The company is headquartered in Adelaide, South Australia. The company went IPO on 2007-06-29. The firm is focused on commercializing generic pharmaceuticals. The firm operates through three segments: International, Branded Products Division (BPD) and Portfolio Products Division (PPD). Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. The BPD segment distributes medically differentiated specialty products in United States. The PPD segment distributes established products (branded and generic) in the United States on a portfolio basis. The firm's products include Doxycycline Capsules, Oxycodone IR Tablets, Erythromycin Capsules and others.

Vanguard Australian Shares High Yield Etf

VHY

VHY.AX was created on 2011-05-26 by Vanguard. The fund's investment portfolio concentrates primarily on high dividend yield equity. Vanguard Australian Shares High Yield ETF seeks to track the return of the FTSE Australia High Dividend Yield Index before taking into account fees, expenses and tax.

Andromeda Metals Limited

ADN

Andromeda Metals Ltd. operates as mineral exploration company, which explores gold, copper and uranium deposits. The company is headquartered in Adelaide, South Australia. Its Great White Kaolin Project covers two geographic areas of interest, both situated in the western province of South Australia. The Project consists of approximately four tenements and is located approximately 635 kilometers (km) west by road from Adelaide and 130 km south-east from Ceduna. The Project is a joint venture between Andromeda Metals and Minotaur Exploration Limited. Its Mount Hope Kaolin Project holds 100% and is located 160 km southeast of the Great White Kaolin Project. Its Camel Lake Halloysite Project is within the Maralinga Tjarutja lands and located approximately 60 km north-east of Ooldea in South Australia. The company is also developing copper and gold prospects across Australia, which include Drummond Epithermal Gold Project, Eyre Peninsula Gold Project, Moonta Copper Gold Project and Eyre Kaolin Project. Its products include Kaolin, Halloysite-kaolin and High Purity Alumina (HPA).

Cardiex Limited

CDX

CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The company is engaged in designing, manufacturing, and marketing medical devices for use in cardiovascular health management, and the development of clinical and consumer digital health solutions. The company is focused on hypertension, cardiovascular disease, and other vascular health disorders. The company operates through its subsidiaries, including ATCOR and CONNEQT. ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its SphygmoCor technology. Under the ATCOR.X brand, it also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. Its digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients’ health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness parameters.

Vanguard MSCI Index International Shares Etf

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.